Impact of timing on the efficacy of omeprazole/sodium bicarbonate 40 mg in healing reflux oesophagitis
Erosive Esophagitis
Enrolment: 91 · Results not recorded
Loading the evidence…
Drug
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Erosive Esophagitis
Enrolment: 91 · Results not recorded
Gastrointestinal Symptoms · Small Intestinal Overgrowth
Enrolment: 100 · Results not recorded
Helicobacter Pylori Infection
Enrolment: 855 · Results not recorded
Gastric Acid
Enrolment: 20 · Results not recorded
Helicobacter Pylori Infection
Enrolment: 180 · Results not recorded
Non-erosive Reflux Disease
Enrolment: 144 · Results not recorded
Peptic Ulcer
Enrolment: 101 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Oesophagoduodenostomy-induced duodenal reflux oesophageal injury, with or without gastrectomy
Acid suppression in the presence of duodenal refluxate increased the incidence of Barrett's mucosa (62 percent with PPI and 71 percent after gastrectomy versus 27 percent with combined reflux), increased erosions and proliferative marker expression, and suppressed acute but not chronic inflammation.
Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.